文献速递运动医学关节外科

肩峰下球囊置入在巨大不可修复肩袖撕裂治疗中较清创术无优势:一项纳入超过1000例患者的双臂系统评价与Meta分析

Subacromial Balloon Placement Demonstrates No Advantage Over Debridement in the Treatment of Massive Irreparable Rotator Cuff Tears: A Dual-Armed Systematic Review and Meta-analysis of Over 1000 Patients.
PubMed 文献 · Am J Sports Med · 2023-06-27

该双臂系统评价与Meta分析比较肩峰下球囊(SAB)置入与关节镜清创治疗巨大不可修复肩袖撕裂(MIRCTs)的疗效,纳入SAB组528例、清创组479例。清创组在疼痛视觉模拟评分(VAS)下降和Constant评分提高方面显著优于SAB组,但两种术式均未达到VAS的患者可接受症状状态。SAB置入总体并发症率较低,但再干预率和再手术率无显著差异,清创组转为反式全肩关节置换术的时间更长。

要点

  • 清创组VAS疼痛评分下降较SAB组多0.7分(P < .001),Constant评分提高较SAB组多5.5分(P < .001)。
  • 清创组总体并发症率5.2% ± 5.6%高于SAB组的3.5% ± 6.3%(P < .001)。
  • 两组再干预率(3.3% ± 6.2% vs 3.8% ± 7.3%,P = .252)和再手术率(5.1% ± 7.6% vs 4.8% ± 8.4%,P = .552)无显著差异。

核心结论

  • SAB置入治疗MIRCTs的术后结果可接受,但较单纯清创无明确获益;清创手术时间更短、术后结果更好且转为反式全肩关节置换术的时间更长,使其成为更具吸引力的选择。作者认为SAB置入可能对手术条件差的患者有作用,但越来越多证据支持单纯清创而不置入SAB治疗MIRCTs。

研究设计与样本

  • 双臂系统评价与Meta分析(IV级证据),检索PubMed(MEDLINE)、Scopus和CINAHL Complete数据库中2022年5月7日前发表的文献;SAB组449篇中14篇符合纳入标准,清创组272篇中14篇符合纳入标准;SAB组528例患者,清创组479例患者。

主要发现

  • 清创组VAS疼痛评分下降较SAB组多0.7分(P < .001),Constant评分提高较SAB组多5.5分(P < .001)。
  • 两种术式均未达到VAS的患者可接受症状状态。
  • SAB置入和清创均显著改善前屈/前举、内旋、外旋和外展活动度(P < .001)。
  • 清创组总体并发症率5.2% ± 5.6%高于SAB组的3.5% ± 6.3%(P < .001)。
  • SAB组与清创组再干预率分别为3.3% ± 6.2%和3.8% ± 7.3%(P = .252),再手术率分别为5.1% ± 7.6%和4.8% ± 8.4%(P = .552),均无显著差异;转为反式全肩关节置换术的平均时间分别为11.0个月和25.4个月。

临床怎么用

  • 作者认为清创手术时间更短、术后结果更好且转为反式全肩关节置换术的时间更长,使其成为更具吸引力的选择;SAB置入可能对手术条件差的患者有作用,但越来越多证据支持单纯清创而不置入SAB治疗MIRCTs。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In recent years, the placement of a subacromial balloon (SAB) spacer has emerged as a treatment option for massive irreparable rotator cuff tears (MIRCTs); however, there is significant controversy regarding its utility in comparison with other surgical interventions. PURPOSE: To compare outcomes after SAB spacer placement versus arthroscopic debridement for MIRCTs. STUDY DESIGN: Dual-armed systematic review and meta-analysis (level IV evidence). METHODS: A literature search of PubMed (MEDLINE), Scopus, and CINAHL Complete databases for articles published before May 7, 2022, was conducted to identify patients with MIRCTs undergoing the 2 procedures. For the SAB arm, 14 of 449 studies were considered eligible for inclusion, while 14 of 272 studies were considered eligible for inclusion in the debridement arm. RESULTS: In total, 528 patients were eligible for inclusion in the SAB arm and 479 patients in the debridement arm, and 69.9% of patients undergoing SAB placement also underwent concomitant debridement. Decreases in the visual analog scale (VAS) pain score and increases in the Constant score were found to be significantly larger after debridement (-0.7 points [P < .001] and +5.5 points [P < .001], respectively), although the Patient Acceptable Symptom State for the VAS was not achieved after either procedure. Both SAB placement and debridement significantly improved range of motion in forward flexion/forward elevation, internal and external rotation, and abduction (P < .001). Rates of general complication were higher after debridement versus SAB placement (5.2% ± 5.6% vs 3.5% ± 6.3%, respectively; P < .001); however, there were no significant differences between SAB placement and debridement in rates of persistent symptoms requiring a reintervention (3.3% ± 6.2% vs 3.8% ± 7.3%, respectively; P = .252) or reoperation rates (5.1% ± 7.6% vs 4.8% ± 8.4%, respectively; P = .552). The mean time to conversion to reverse total shoulder arthroplasty was 11.0 versus 25.4 months, respectively, for the SAB versus debridement arm. CONCLUSION: While SAB placement was associated with acceptable postoperative outcomes in the treatment of MIRCTs, there was no clear benefit over debridement alone. Shorter operative times coupled with better postoperative outcomes and longer times to conversion to reverse total shoulder arthroplasty rendered debridement a more attractive option. While there may be a role for SAB placement in poor surgical candidates, there is burgeoning evidence to support debridement alone without SAB placement for the treatment of MIRCTs.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Sandler AB, Gil LG, Scanaliato JP, et al. Subacromial Balloon Placement Demonstrates No Advantage Over Debridement in the Treatment of Massive Irreparable Rotator Cuff Tears: A Dual-Armed Systematic Review and Meta-analysis of Over 1000 Patients. Am J Sports Med. 2023. PMID: 37369101. doi:10.1177/03635465231168127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。